39106 (2024). Hon Dr Ayesha Verrall to the Minister of Health

Written Question

Published date: 14 Jul 2024

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	39106 (2024)
Question asked:	30 Jun 2024
Member asking:	Hon Dr Ayesha Verrall
Portfolio:	Minister of Health
Minister replying:	Hon Dr Shane Reti
Answer received:	08 Jul 2024
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_39106_2024
Document guid:	3b4d9c80-8dbc-4d99-85d0-ed98b42f39db

39106 (2024). Hon Dr Ayesha Verrall to the Minister of Health: What progress has been made in the last quarter (January to March 2024) to ‘Improve the detection and management of hepatitis B and C’ under Outcome 3: New Zealanders have fewer cancers, as part of the New Zealand Cancer Action Plan 2019 – 2029?

Hon Dr Shane Reti: I am advised during the January to March 2024 quarter, several initiatives were progressed. These included:   - The network of Hepatitis C Point of Care testing community providers was further expanded across New Zealand. - A prototype Hepatitis C Support and Treatment telehealth service was launched. - Pilot studies to test general population screening for Hepatitis C in community laboratories and in emergency departments were progressed. - An online training programme to support the reclassification of Maviret for nurses and pharmacists was developed. - Planning for a public campaign to raise awareness of Hepatitis C is underway.